Goodwin

Kuwabo Mubyana

Deals
2
Latest
Apr 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 2 deals

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Kuwabo Mubyana was named on, most recent first
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis
Jan 2026 Aktis Oncology ––IPOLegal adviser to the issuerListed317.7Biotech+2Aktis Oncology IPO

Deals where Kuwabo Mubyana is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.